Profusa, Inc. (PFSA) News
Track canonical SquawkNews coverage tagged to PFSA, Profusa, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 14 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Profusa Signs Option For G3 Vision Labs Acquisition
Profusa to acquire diagnostics company
MNA | Jul 31, 2026, 09:15 PM UTC
L
Top Small Cap Negative News Movers Premarket: STAK: -54% Momentum Mover OMH: -40% Pricing of $4 Million Registered Direct Offering WETO: -35
Top Small Cap Negative News Movers Premarket: STAK: -54% Momentum Mover OMH: -40% Pricing of $4 Million Registered Direct Offering WETO: -35% to Enter into Warehouse Robotics Cooperation Agreement OFAL: -25% 1-for-10 Con
EQUITY | Jul 27, 2026, 12:16 PM UTC
H
Why Is Profusa Stock Falling Monday?
Profusa Inc. (NASDAQ: PFSA ) stock fell in Monday premarket trading after the company announced leadership changes and signed a non-binding acquisition term sheet. PFSA has lost about 99.95% of its value over the past 12
RATES | Jul 27, 2026, 11:46 AM UTC
H
Profusa To Merge With Privately Held, Commercial-Stage Health Diagnostics And Toxicology Testing Company; Profusa To Issue 19.99% Stake to T
Following the contemplated transaction, the combined company is expected to operate as a public diagnostics company with national CLIA-certified laboratories, recurring revenues from a diversified base of providers servi
RATES | Jul 27, 2026, 10:05 AM UTC
L
PFSA - Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics
PFSA - Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
EQUITY | Jul 27, 2026, 10:00 AM UTC
L
Profusa shares are trading lower after the company announced a 1-for-25 reverse stock split.
Profusa shares are trading lower after the company announced a 1-for-25 reverse stock split.
EQUITY | Jul 02, 2026, 03:12 PM UTC
L
Profuse Announces 1-For-25 Reverse Stock Split, Effective July 7
Profusa, Inc. ("Profusa" or the "Company") (NASDAQ: PFSA ), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, t
EQUITY | Jul 02, 2026, 03:03 PM UTC
L
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Curis (NASDAQ: CRIS ) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million. Humacyte (NASDAQ: HUMA ) shares moved upwards by 5.45% to $0.71. The marke
EQUITY | Jul 01, 2026, 09:05 PM UTC
H
Small Caps Fall
Several small cap stocks are experiencing significant declines premarket due to various news announcements.
EQUITY | Jun 24, 2026, 01:13 PM UTC
H
Small Caps Fall
Several small cap stocks are experiencing significant declines premarket due to various reasons including reverse splits, momentum moves, and new offerings.
EQUITY | Jun 24, 2026, 12:21 PM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Wednesday's pre-market session, with Pulsenmore and Catheter Precision leading the gainers and Nuwellis and Mobile-health Network leading the losers
EQUITY | Jun 24, 2026, 12:09 PM UTC
H
PFSA Acquires PanOmics
Profusa shareholders approve acquisition of PanOmics multi-omics diagnostics platform and reverse stock split
EQUITY | Jun 24, 2026, 12:07 PM UTC
M
PFSA Approves Strategic Initiatives
Profusa shareholders approve strategic initiatives at 2026 annual meeting, supporting PanOmics acquisition and balance sheet strengthening
EARNINGS | Jun 24, 2026, 12:01 PM UTC
M
PFSA Approves Stock Split
Profusa shareholders approve amendment for common stock split at ratio of 1-to-5 to 1-for-200 over next two years
EQUITY | Jun 23, 2026, 05:16 PM UTC